SpectraScience, Inc.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, BMXXY has a market cap of 16.3B. Regarding current trading prices, SCIE is priced at $0.00, while BMXXY trades at $13.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas BMXXY's P/E ratio is 32.93. In terms of profitability, SCIE's ROE is +0.00%, compared to BMXXY's ROE of +0.10%. Regarding short-term risk, SCIE is less volatile compared to BMXXY. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, EBOSY has a market cap of 2.1B. Regarding current trading prices, SCIE is priced at $0.00, while EBOSY trades at $41.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas EBOSY's P/E ratio is 22.92. In terms of profitability, SCIE's ROE is +0.00%, compared to EBOSY's ROE of +0.08%. Regarding short-term risk, SCIE is less volatile compared to EBOSY. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, XVIPY has a market cap of 718.2M. Regarding current trading prices, SCIE is priced at $0.00, while XVIPY trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas XVIPY's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to XVIPY's ROE of +0.10%. Regarding short-term risk, SCIE is less volatile compared to XVIPY. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, EBRCZ has a market cap of 204.4M. Regarding current trading prices, SCIE is priced at $0.00, while EBRCZ trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas EBRCZ's P/E ratio is -4.57. In terms of profitability, SCIE's ROE is +0.00%, compared to EBRCZ's ROE of -2.89%. Regarding short-term risk, SCIE is less volatile compared to EBRCZ. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, TRXDW has a market cap of 40.1M. Regarding current trading prices, SCIE is priced at $0.00, while TRXDW trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas TRXDW's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to TRXDW's ROE of -5.59%. Regarding short-term risk, SCIE and TRXDW have similar daily volatility (0.00).

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, NVNBW has a market cap of 9.6M. Regarding current trading prices, SCIE is priced at $0.00, while NVNBW trades at $0.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas NVNBW's P/E ratio is -0.28. In terms of profitability, SCIE's ROE is +0.00%, compared to NVNBW's ROE of -0.51%. Regarding short-term risk, SCIE and NVNBW have similar daily volatility (0.00).

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, GWPC has a market cap of 52K. Regarding current trading prices, SCIE is priced at $0.00, while GWPC trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas GWPC's P/E ratio is -0.01. In terms of profitability, SCIE's ROE is +0.00%, compared to GWPC's ROE of N/A. Regarding short-term risk, SCIE and GWPC have similar daily volatility (0.00).

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, SXHHF has a market cap of 38.1K. Regarding current trading prices, SCIE is priced at $0.00, while SXHHF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas SXHHF's P/E ratio is -0.01. In terms of profitability, SCIE's ROE is +0.00%, compared to SXHHF's ROE of +1.13%. Regarding short-term risk, SCIE is less volatile compared to SXHHF. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, DGCRF has a market cap of 21.5K. Regarding current trading prices, SCIE is priced at $0.00, while DGCRF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas DGCRF's P/E ratio is 0.00. In terms of profitability, SCIE's ROE is +0.00%, compared to DGCRF's ROE of -1.11%. Regarding short-term risk, SCIE is less volatile compared to DGCRF. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, KKUR has a market cap of 8.2K. Regarding current trading prices, SCIE is priced at $0.00, while KKUR trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas KKUR's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to KKUR's ROE of N/A. Regarding short-term risk, SCIE is less volatile compared to KKUR. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, OMRX has a market cap of 5.3K. Regarding current trading prices, SCIE is priced at $0.00, while OMRX trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas OMRX's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to OMRX's ROE of -0.15%. Regarding short-term risk, SCIE is less volatile compared to OMRX. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, IBXG has a market cap of 2K. Regarding current trading prices, SCIE is priced at $0.00, while IBXG trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas IBXG's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to IBXG's ROE of N/A. Regarding short-term risk, SCIE is less volatile compared to IBXG. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, DMSI has a market cap of 1.9K. Regarding current trading prices, SCIE is priced at $0.00, while DMSI trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas DMSI's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to DMSI's ROE of -0.32%. Regarding short-term risk, SCIE is less volatile compared to DMSI. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, AAXT has a market cap of 1.6K. Regarding current trading prices, SCIE is priced at $0.00, while AAXT trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas AAXT's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to AAXT's ROE of +0.54%. Regarding short-term risk, SCIE and AAXT have similar daily volatility (0.00).

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, XCRP has a market cap of 1.5K. Regarding current trading prices, SCIE is priced at $0.00, while XCRP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas XCRP's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to XCRP's ROE of -3.49%. Regarding short-term risk, SCIE and XCRP have similar daily volatility (0.00).

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, BMGP has a market cap of 1.3K. Regarding current trading prices, SCIE is priced at $0.00, while BMGP trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas BMGP's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to BMGP's ROE of -0.50%. Regarding short-term risk, SCIE is less volatile compared to BMGP. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, IMRSQ has a market cap of 626. Regarding current trading prices, SCIE is priced at $0.00, while IMRSQ trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas IMRSQ's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to IMRSQ's ROE of -1.30%. Regarding short-term risk, SCIE is less volatile compared to IMRSQ. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, STBV has a market cap of 472. Regarding current trading prices, SCIE is priced at $0.00, while STBV trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas STBV's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to STBV's ROE of -1.13%. Regarding short-term risk, SCIE is less volatile compared to STBV. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, OMDD has a market cap of 310. Regarding current trading prices, SCIE is priced at $0.00, while OMDD trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas OMDD's P/E ratio is N/A. In terms of profitability, SCIE's ROE is +0.00%, compared to OMDD's ROE of N/A. Regarding short-term risk, SCIE is less volatile compared to OMDD. This indicates potentially lower risk in terms of short-term price fluctuations for SCIE.

SCIE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, SCIE stands at 492.4K. In comparison, QMED has a market cap of 17. Regarding current trading prices, SCIE is priced at $0.00, while QMED trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

SCIE currently has a P/E ratio of -0.01, whereas QMED's P/E ratio is -0.00. In terms of profitability, SCIE's ROE is +0.00%, compared to QMED's ROE of N/A. Regarding short-term risk, SCIE and QMED have similar daily volatility (0.00).